tetano
Editor, Senior Moderator
Cureus
. 2024 May 2;16(5):e59538.
doi: 10.7759/cureus.59538. eCollection 2024 May. Myasthenia Gravis Triggered by a COVID-19 Infection: A Case Report and Literature Review
Alexandra Mincă[SUP] 1 2 [/SUP], Dragos I Mincă[SUP] 3 4 [/SUP], Amalia L Calinoiu[SUP] 2 [/SUP], Valeriu Gheorghiță[SUP] 5 6 [/SUP], Claudiu C Popescu[SUP] 7 4 [/SUP], Adina Rusu[SUP] 2 [/SUP], Alexandra M Cristea[SUP] 8 9 [/SUP], Dana G Mincă[SUP] 1 [/SUP]
Affiliations
Myasthenia gravis (MG) is an autoimmune disease that induces skeletal muscle weakness, affecting different muscle groups. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of coronavirus disease 2019 (COVID-19), became both a diagnostic and a therapeutic challenge during the pandemic. The effects of COVID-19 are not only limited to the acute symptoms but also to the post-infectious sequelae. We present the case of a 30-year-old Caucasian woman, with no significant medical history, who presented to the emergency room with acute respiratory failure. The patient tested positive for SARS-CoV-2 with a rapid antigen test and during hospitalization developed a myasthenic crisis, ultimately being diagnosed with seropositive MG.
Keywords: autoimmune diseases; coronavirus disease 2019; covid-19; myasthenia gravis (mg); sars-cov-2.
. 2024 May 2;16(5):e59538.
doi: 10.7759/cureus.59538. eCollection 2024 May. Myasthenia Gravis Triggered by a COVID-19 Infection: A Case Report and Literature Review
Alexandra Mincă[SUP] 1 2 [/SUP], Dragos I Mincă[SUP] 3 4 [/SUP], Amalia L Calinoiu[SUP] 2 [/SUP], Valeriu Gheorghiță[SUP] 5 6 [/SUP], Claudiu C Popescu[SUP] 7 4 [/SUP], Adina Rusu[SUP] 2 [/SUP], Alexandra M Cristea[SUP] 8 9 [/SUP], Dana G Mincă[SUP] 1 [/SUP]
Affiliations
- PMID: 38827012
- PMCID: PMC11144031
- DOI: 10.7759/cureus.59538
Myasthenia gravis (MG) is an autoimmune disease that induces skeletal muscle weakness, affecting different muscle groups. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of coronavirus disease 2019 (COVID-19), became both a diagnostic and a therapeutic challenge during the pandemic. The effects of COVID-19 are not only limited to the acute symptoms but also to the post-infectious sequelae. We present the case of a 30-year-old Caucasian woman, with no significant medical history, who presented to the emergency room with acute respiratory failure. The patient tested positive for SARS-CoV-2 with a rapid antigen test and during hospitalization developed a myasthenic crisis, ultimately being diagnosed with seropositive MG.
Keywords: autoimmune diseases; coronavirus disease 2019; covid-19; myasthenia gravis (mg); sars-cov-2.